Endometrial ablation devices: Review of a manufacturer and user facility device experience database

Journal of Minimally Invasive Gynecology

Volumn 14, Issue 4, 2007, Pages 436-441

  Della Badia, Carl ^a   Nyirjesy, Paul ^a   Atogho, Ata ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Endometrial ablation; Endometrial ablation complications; MAUDE database; Surgical complications

Indexed keywords

BLEEDING; BURN; COMPARATIVE STUDY; DATA BASE; DEVICE; DISEASE SEVERITY; ENDOCARDITIS; ENDOMETRIUM ABLATION; HEMATOMETRA; HUMAN; HYSTERECTOMY; INFECTION; INTESTINE INJURY; MICROWAVE IRRADIATION; PELVIC INFLAMMATORY DISEASE; PELVIS PAIN SYNDROME; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; REVIEW; SURGICAL EQUIPMENT; SYSTEMATIC REVIEW; UNITED STATES; URINARY TRACT INJURY; UTERUS PERFORATION;

CAUTERY; DATABASES; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; POSTOPERATIVE COMPLICATIONS;

EID: 34447279041     PISSN: 15534650     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmig.2007.05.008     Document Type: Review

References (17)

1. United States Food and Drug Administration. Medical Device Reporting (MDR) - General Information (2007). http://www.fda.gov/cdrh/mdr/mdr-general.html Available at: http://www.fda.gov/cdrh/mdr/mdr-general.html. Accessed June 5.
2. United States Food and Drug Administration. Search MAUDE Database (2007). http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/search.cfm?searchoptions=1 Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/search.cfm?searchoptions=1. Accessed June 5.
3. Goldrath M.H., Fuller T.A., and Segal S. Laser photovaporization of endometrium for the treatment of menorrhagia. Am J Obstet Gynecol 140 (1981) 14-19
4. DeCherney A.H., Diamond M.P., Lavy G., and Polan M.L. Endometrial ablation for intractable uterine bleeding: hysteroscopic resection. Obstet Gynecol 70 (1987) 668-670
5. Vancaillie T.G. Electrocoagulation of the endometrium with the ball-end resectoscope. Obstet Gynecol 74 (1989) 425-427
6. Cooper J.M., and Brady R.M. Intraoperative and early postoperative complications of operative hysteroscopy. Obstet Gynecol Clin North Am 27 (2000) 347-366
7. Summary of Safety and Effectiveness Data: ThermaChoice Uterine Balloon Therapy System, Gynecare, Inc. (1997), US Food and Drug Administration, Center of Devices and Radiologic Health, Rockville, MD PMA P970021.
8. Summary of Safety and Effectiveness Data: Her Option Uterine Cryoablation Therapy System, Cryogen, Inc. (2001), US Food and Drug Administration, Center of Devices and Radiologic Health, Rockville, MD PMA P000032b.
9. Summary of Safety and Effectiveness Data: Hydro ThermAblator Endometrial Ablation System, BEI Medical Systems Company, Inc. (2001), US Food and Drug Administration, Center of Devices and Radiologic Health, Rockville, MD PMA P000040.
10. Summary of Safety and Effectiveness Data: NovaSure Impedance Controlled Endometrial Ablation System, Novacept, Inc. (2001), US Food and Drug Administration, Center for Devices and Radiologic Health, Rockville, MD PMA P010013.
11. Summary of Safety and Effectiveness Data: Microsulis Microwave Endometrial Ablation (MEA) System, Microsulis, Inc (2003), US Food and Drug Administration, Center for Devices and Radiologic Health, Rockville, MD PMA PO20031.
12. Cooper J., and Gimpelson R.J. Summary of safety and effectiveness data from FDA: a valuable source of information on the performance of global endometrial ablation devices. J Reprod Med 49 (2004) 267-273
13. Gurtcheff S.E., and Sharp H.T. Complications associated with global endometrial ablation: the utility of the MAUDE database. Obstet Gynecol 102 (2003) 1278-1282
14. Weisberg M. Complications associated with global endometrial ablation: the utility of the MAUDE database. Obstet Gynecol 103 (2004) 995-996
15. US Food and Drug Administration. (MAUDE) File Formats for FOI Releasable Data Available at: http://www.fda.gov/cdrh/maude.html. Accessed June 5, 2007.
16. US Food and Drug Administration. FDA Announces Membership of Drug Safety Oversight Board (2007). http://www.fda.gov/bbs/topics/ANSWERS/2005/ANS01359.html Available at: http://www.fda.gov/bbs/topics/ANSWERS/2005/ANS01359.html. Accessed June 5.
17. Farquhar C.M., Naoom S., and Steiner C.A. The impact of endometrial ablation on hysterectomy rates in women with benign uterine conditions in the United States. Int J Technol Assess Health Care 18 (2002) 625-634